Evolving clinical application of cardiac MRI

Reviews in Cardiovascular Medicine

Volumn 8, Issue 3, 2007, Pages 135-144

  Alfayoumi, Fadi ^a   Gradman, Alan ^a   Traub, Darren ^a   Biederman, Robert ^b  

^a WESTERN PENNSYLVANIA HOSPITAL   (United States)

^b ALLEGHENY GENERAL HOSPITAL   (United States)

Author keywords

Cardiac magnetic resonance imaging; Cardiomyopathy; Constrictive pericarditis; Myocardial viability; Myocarditis

Indexed keywords

CONGESTIVE CARDIOMYOPATHY; CONSTRICTIVE PERICARDITIS; CONTRAST ENHANCEMENT; HEART FUNCTION; HEART PERFUSION; HUMAN; MYOCARDITIS; NON INVASIVE MEASUREMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; REPRODUCIBILITY; REVIEW;

CARDIOMYOPATHIES; CARDIOMYOPATHY, DILATED; CORONARY ARTERY DISEASE; HUMANS; MAGNETIC RESONANCE IMAGING; MYOCARDITIS; PERICARDITIS, CONSTRICTIVE;

EID: 34848899849     PISSN: 15306550     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (43)

1. Bushong SC. Magnetic Resonance Imaging: Physical and Biological Principles, 3rd ed. St. Louis, MO: CV Mosby; 2003.
2. Higgins CB, de Roos A. Cardiovascular MRI & MRA. Baltimore, MD: Lippincott Williams and Wilkins; 2002.
3. Firmin DN, Nayler GL, Kilner PJ, Longmore DB. The application of phase shifts in NMR for flow measurement. Magn Reson Med. 1990;14:230-241.
4. Niendorf HP, Haustein J, Cornelius I, et al. Safety of gadolinium-DTPA: extended clinical experience. Magn Reson Med. 1991;22:222-232.
5. Manning WJ, Atkinson DJ, Grossman W, et al. First-pass nuclear magnetic resonance imaging studies using gadolinium-DTPA in patients with coronary artery disease. J Am Coll Cardiol. 1991;18:959-965.
6. Masui T, Finck S, Higgins CB. Constrictive pericarditis and restrictive cardiomyopathy: evaluation with MR imaging. Radiology. 1992; 182:369-373.
7. Hayashi H, Kawamata H, Machida M, et al. Tuberculous pericarditis: MRI features with contrast enhancement. Br J Radiol. 1998;71: 680-682.
8. Kovanlikaya A, Burke LP, Nelson MD, et al. Characterizing chronic pericarditis using steady-state free-precession cine MR imaging. Am J Roentgenol. 2002;179:475-476.
9. Wang ZJ, Reddy GP, Gotway MB, et al. CT and MR imaging of pericardial disease. Radiographics. 2003;23:S167-S180.
10. Bart BA, Shaw LK, McCants CB, et al. Clinical determinants of mortality in patients with angiographically diagnosed ischemic or non-ischemic cardiomyopathy. J Am Coll Cardiol. 1997;30:1002-1008.
11. Olson TM, Illenberger S, Kishimoto NY, et al. Metavinculin mutations alter actin interaction in dilated cardiomyopathy. Circulation. 2002; 105:431-437.
12. Uretsky BF, Thygesen K, Armstrong PW, et al. Acute coronary findings at autopsy in heart failure patients with sudden death: results from the Assessment of Treatment with Lisinopril And Survival (ATLAS) trial. Circulation. 2000; 102:611-616.
13. McCrohon JA, Moon JCC, Prasad SK. Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation. 2003;108:54-59.
14. Kishimoto C, Hiraoka Y. Clinical and experimental studies in myocarditis. Curr Opin Cardiol. 1994;9:349-356.
15. Theleman KP, Kuiper JJ, Roberts WC. Acute myocarditis sudden death without heart failure. Am J Cardiol. 2001;88:1078-1083.
16. Kubo N, Morimoto S, Hiramitsu S, et al. Feasibility of diagnosing chronic myocarditis by endomyocardial biopsy. Heart Vessels. 1997;12: 167-170.
17. Mahrholdt H, Goedecke C, Wagner A, et al. Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology. Circulation. 2004;109:1250-1258.
18. Fredrich M, Strohm O, Schulz-Menger J. Contrast media enhanced MRI visualize myocardial changes in the course of viral myocarditis. Circulation. 1998;97:1802-1809.
19. Allman KC, Shaw LJ, Hachamovitch R, Udelson JE. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J Am Coll Cardiol. 2002;39:1151-1158.
20. Pagley PR, Beller GA, Watson DD, et al. Improved outcome after coronary bypass surgery in patients with ischemic cardiomyopathy and residual myocardial viability. Circulation. 1997;96:793-800.
21. Haas F, Haenel CJ, Picker W. Preoperative positron emission tomographic viability assessment and perioperative and postoperative risk in patients with advanced ischemic heart disease. J Am Coll Cardiol. 1997;30:1693-1700.
22. Chaudhry FA, Tauke JT, Alessandrini RS, et al. Prognostic implications of myocardial contractile reserve in patients with coronary artery disease and left ventricular dysfunction. J Am Coll Cardiol. 1999;32:912-920.
23. Dilsizian V, Rocco TP, Freddman NMT, et al. Enhanced detection of ischemic but viable myocardium by the reinjection of thallium after stress-redistribution imaging. N Engl J Med. 1990;323:141-146.
24. Pierard LA, De Landsheere CM, Berthe C, et al. Identification of viable myocardium by echocardiography during dobutamine infusion in patients with myocardial infarction after thrombolytic therapy: comparison with positron emission tomography. J Am Coll Cardiol. 1990;15:1021-1031.
25. Tillisch JH, Brunke R, Marshall R, et al. Reversibility of cardiac wall-motion abnormalities predicted by positron tomography. N Engl J Med. 1986;314:884-888.
26. Thomson LEJ, Kim RJ, Judd RM. Magnetic resonance imaging for the assessment of myocardial viability. J Magn Reson Imaging. 2004;19: 771-788.
27. Choi KM, Kim RJ, Gubernikoff G, et al. Transmural extent of acute myocardial infarction predicts long-term improvement in contractile function. Circulation. 2001;104:1101-1107.
28. Kim RJ, Wu E, Rafael A, et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med. 2000;343:1445-1453.
29. Bello D, Shah DJ, Farah GM, et al. Gadolinium cardiovascular magnetic resonance predicts reversible myocardial dysfunction and remodeling in patients with heart failure undergoing beta-blocker therapy. Circulation. 2003;108: 1945-1953.
30. Bellenger NG, Ra|appan K, Rahman SL, et al. Effects of carvedilol on left ventricular remodelling in chronic stable heart failure: a cardiovascular magnetic resonance study. Heart. 2004;90:760-764.
31. Cleland JG, Pennell DJ, Ray SG, et al. Myocardial viability as a determinant of the ejection fraction response to carvedilol in patients with heart failure (CHRISTMAS trial). Lancet. 2003; 362:14-21.
32. Kuhl HP, Beek AM, van der Weerdt AP, et al. Myocardial viability in chronic ischemic heart disease: comparison of contrast-enhanced magnetic resonance imaging with (18)F-fluorodeoxyglucose positron emission tomography. J Am Coll Cardiol. 2003;41:1341-1348.
33. Kim WY, Danias PG, Stuber M, et al. Coronary magnetic resonance angiography for the detection of coronary stenoses. N Engl J Med. 2001;345:1863-1869.
34. Flamm S, Muthupillai R. Coronary artery magnetic resonance angiography. J Magn Reson Imaging. 2004;19:686-702.
35. Bunce NH, Lorenz CH, Keegan J, et al. Coronary artery anomalies: assessment with free-breathing three-dimensional coronary MR angiography. Radiology. 2003;227:201-208.
36. McConnell MV, Ganz P, Selwyn AP, et al. Identification of anomalous coronary arteries and their anatomic course by magnetic resonance coronary angiography. Circulation. 1995;92: 3158-3162.
37. Post JC, van Rossum AC, Bronzwaer JG, et al. Magnetic resonance angiography of anomalous coronary arteries. A new gold standard for delineating the proximal course. Circulation. 1995;92:3163-3171.
38. Vliegen HW, Doornbos J, de Roos A, et al. Value of fast gradient echo magnetic resonance angiography as an adjunct to coronary arteriography in detecting and confirming the course of clinically significant coronary artery anomalies. Am J Cardiol. 1997;79:773-776.
39. Mavrogeni S, Papadopoulos G, Douskou M, et al. Magnetic resonance angiography is equivalent to x-ray coronary angiography for the evaluation of coronary arteries in Kawasaki disease. J Am Coll Cardiol. 2004;43:649-652.
40. Bisset GS, Strife JL, McCloskey J. MR imaging of coronary artery aneurysms in a child with Kawasaki disease. Am J Roentgenol. 1989;152: 805-807.
41. Duerinckx AJ, Troutman B, Allada V, et al. Coronary MR angiography in Kawasaki disease. Am J Roentgenol. 1997;168:114-116.
42. Greil GF, Stuber M, Botnar RM, et al. Coronary magnetic resonance angiography in adolescents and young adults with Kawasaki disease. Circulation. 2002;105:908-911.
43. Axel L. Assessment of pericardial disease by magnetic resonance and computed tomography. J Magn Reson Imaging. 2004;19:816-826.